Skip to main content

Table 3 ICEP patient treatment and evolution

From: Idiopathic eosinophilic pneumonia in children: the French experience

Patient Treatment Evolution
Initial treatment Duration (months) Response Total length of follow-up (years) Relapse (number) Delay after the end of the initial regimen (years) Maintenance oral CS Clinical evolution Last CT scan Last spirometry
1 oral CS § 1 mg/kg/day 4 Total 1.5 0 _ _ _ m9: normal (1 nodule) D
2 oral CS § 2 mg/kg/day 2 Total 5.9 0 _ _ asthma m1: mild bronchiectasis pO
3 oral CS * 1 mg/kg/day 4 Partial 8.1 2 0.8 0.07 mg/kg/day asthma y7: interstitial opacities and cysts R, pO
4 cyclosporine 5 mg/kg/day 39 Total 3.2 0 _ _ asthma y3: normal mild R (obesity)
5 9 IV pulse + oral CS § 2 mg/kg/day 12 Partial 7.2 1 6.1 _ asthma y6: interstitial opacities and cysts normal
  1. Footnote: § prednisolone, * prednisone, IV: intravenous methylprednisolone, CS: corticosteroid therapy, D: diffusion impairment, R: restriction, pO: peripheral obstruction ,m: month, y: year.